1. Home
  2. CPRX vs PTEN Comparison

CPRX vs PTEN Comparison

Compare CPRX & PTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • PTEN
  • Stock Information
  • Founded
  • CPRX 2002
  • PTEN 1978
  • Country
  • CPRX United States
  • PTEN United States
  • Employees
  • CPRX N/A
  • PTEN N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • PTEN Oil & Gas Production
  • Sector
  • CPRX Health Care
  • PTEN Energy
  • Exchange
  • CPRX Nasdaq
  • PTEN Nasdaq
  • Market Cap
  • CPRX 2.9B
  • PTEN 2.3B
  • IPO Year
  • CPRX 2006
  • PTEN 1993
  • Fundamental
  • Price
  • CPRX $21.81
  • PTEN $6.51
  • Analyst Decision
  • CPRX Strong Buy
  • PTEN Buy
  • Analyst Count
  • CPRX 6
  • PTEN 13
  • Target Price
  • CPRX $32.83
  • PTEN $9.85
  • AVG Volume (30 Days)
  • CPRX 1.4M
  • PTEN 11.7M
  • Earning Date
  • CPRX 08-06-2025
  • PTEN 07-23-2025
  • Dividend Yield
  • CPRX N/A
  • PTEN 4.89%
  • EPS Growth
  • CPRX 178.13
  • PTEN N/A
  • EPS
  • CPRX 1.57
  • PTEN N/A
  • Revenue
  • CPRX $534,645,999.00
  • PTEN $5,148,088,000.00
  • Revenue This Year
  • CPRX $16.37
  • PTEN N/A
  • Revenue Next Year
  • CPRX $8.80
  • PTEN N/A
  • P/E Ratio
  • CPRX $13.93
  • PTEN N/A
  • Revenue Growth
  • CPRX 29.97
  • PTEN 5.82
  • 52 Week Low
  • CPRX $15.34
  • PTEN $5.12
  • 52 Week High
  • CPRX $26.58
  • PTEN $11.27
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 42.36
  • PTEN 58.50
  • Support Level
  • CPRX $20.62
  • PTEN $6.37
  • Resistance Level
  • CPRX $22.06
  • PTEN $6.69
  • Average True Range (ATR)
  • CPRX 0.66
  • PTEN 0.29
  • MACD
  • CPRX 0.03
  • PTEN 0.05
  • Stochastic Oscillator
  • CPRX 56.67
  • PTEN 81.86

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About PTEN Patterson-UTI Energy Inc.

Patterson-UTI Energy Inc is one of the substantial land rig drilling contractors in the United States. Its 2023 merger with NexTier greatly expanded its pressure pumping operations, as well, and the firm now controls nearly 20% of the North American market for drilling and completions services. The company operates under three reportable business segments: (i) drilling services, (ii) completion services, and (iii) drilling products. It also provides directional drilling services and tool rental services in united states onshore oil and gas basins.

Share on Social Networks: